
Please try another search
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Lars Lind | 84 | 2024 | Independent Director |
Sten Nilsson | 77 | 2017 | Independent Director |
Alain Herrera | 75 | 2017 | Independent Director |
Helena Taflin | 52 | 2024 | Independent Director |
Heinz-Josef Lenz | 65 | 2025 | Member of Advisory Board |
Sebastian Stintzing | - | 2025 | Member of Advisory Board |
Takayuki Yoshino | - | 2025 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review